|
No records
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Malnutrition and depression as predictors for 30-day unplanned readmission in older patient: a prospective cohort study to develop 7-point scoring system |
Fitriana I., Setiati S., Rizal E.W., Istanti R., Rinaldi I., Kojima T., Akishita M., Azwar M.K. |
BMC Geriatrics |
|
Q1 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Immunomodulatory effect of in vitro calcitriol in fit and frail elderly |
Rizka A., Setiati S., Sadikin M., Mansur I.G. |
International Immunopharmacology |
|
Q1 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Frailty and Its Associated Risk Factors: First Phase Analysis of Multicentre Indonesia Longitudinal Aging Study |
Setiati S., Soejono C.H., Harimurti K., Dwimartutie N., Aryana I.G.P.S., Sunarti S., Budiningsih F., Mulyana R., Dwipa L., Sudarso A., Rensa R., Istanti R., Azwar M.K., Marsigit J. |
Frontiers in Medicine |
|
Q1 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis: Clinical Frailty Scale in COVID-19 |
Pranata R., Henrina J., Lim M.A., Lawrensia S., Yonas E., Vania R., Huang I., Lukito A.A., Suastika K., Kuswardhani R.A.T., Setiati S. |
Archives of Gerontology and Geriatrics |
16 |
Q1 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Prevalence of lactose intolerance and nutrients intake in an older population regarded as lactase non-persistent |
Dewiasty E., Setiati S., Agustina R., Roosheroe A.G., Abdullah M., Istanti R., de Groot L.C. |
Clinical Nutrition ESPEN |
|
Q3 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Thrombocytopenia as a prognostic marker in COVID-19 patients: Diagnostic test accuracy meta-analysis |
Pranata R., Lim M.A., Yonas E., Huang I., Nasution S.A., Setiati S., Alwi I., Kuswardhani R.A.T. |
Epidemiology and Infection |
2 |
Q2 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Modifiable Risk Factors for Dementia in Indonesia's Urban Population |
Azwar M.K., Setiati S. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
14325991900 |
Siti Setiati |
Prof. Dr. dr. Siti Setiati, SpPD-KGer, M.Epid, FINASIM |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive? |
Setiati S., Marsigit J. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
No records
|
|
6508327402 |
Soehartati Argadikoesoema |
Prof. Dr. dr. Soehartati Argadikoesoema, SpRad(K), OnkRad |
Departemen Radiologi |
Onkologi Radiasi (Sp-1) |
The potential of gallic acid as a radiosensitizer on human prostate cancer: A systematic review of preclinical studies |
Cahyono A.T., Louisa M., Mayang Permata T.B., Handoko, Nuryadi E., Kodrat H., Wibowo H., Hariandy Hamid A.R.A., Sekarutami S.M., Gondhowiardjo S.A. |
Malaysian Journal of Medicine and Health Sciences |
|
Q4 |
|
|
|
6508327402 |
Soehartati Argadikoesoema |
Prof. Dr. dr. Soehartati Argadikoesoema, SpRad(K), OnkRad |
Departemen Radiologi |
Onkologi Radiasi (Sp-1) |
The Practice of Paediatric Radiation Oncology in Low- and Middle-income Countries: Outcomes of an International Atomic Energy Agency Study |
Anacak Y., Zubizarreta E., Zaghloul M., Laskar S., Alert J., Gondhowiardjo S., Giselvania A., Correa-Villar R., Pedrosa F., Dorj B., Kamer S., Howard S.C., Quintana Y., Ribeiro R.C., Rosenblatt E., Hopkins K. |
Clinical Oncology |
|
Q1 |
|
|
